首页> 外文期刊>Microbiome >Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice
【24h】

Transplanted human fecal microbiota enhanced Guillain Barré syndrome autoantibody responses after Campylobacter jejuni infection in C57BL/6 mice

机译:在C57BL / 6小鼠中空肠弯曲杆菌感染后,移植的人粪便微生物群增强了GuillainBarré综合征自身抗体反应

获取原文
获取外文期刊封面目录资料

摘要

Background Campylobacter jejuni is the leading antecedent infection to the autoimmune neuropathy Guillain-Barré syndrome (GBS), which is accompanied by an autoimmune anti-ganglioside antibody attack on peripheral nerves. Previously, we showed that contrasting immune responses mediate C. jejuni induced colitis and autoimmunity in interleukin-10 (IL-10)-deficient mice, dependent upon the infecting strain. Strains from colitis patients elicited T helper 1 (TH1)-dependent inflammatory responses while strains from GBS patients elicited TH2-dependent autoantibody production. Both syndromes were exacerbated by antibiotic depletion of the microbiota, but other factors controlling susceptibility to GBS are unknown. MethodsUsing 16S rRNA gene high-throughput sequencing, we examined whether structure of the gut microbial community alters host (1) gastrointestinal inflammation or (2) anti-ganglioside antibody responses after infection with C. jejuni strains from colitis or GBS patients. We compared these responses in C57BL/6 mice with either (1) stable human gut microbiota (Humicrobiota) transplants or (2) conventional mouse microbiota (Convmicrobiota). ResultsInoculating germ-free C57BL/6 wild-type (WT) mice with a mixed human fecal slurry provided a murine model that stably passed its microbiota over >20 generations. Mice were housed in specific pathogen-free (SPF) facilities, while extra precautions of having caretakers wear sterile garb along with limited access ensured that no mouse pathogens were acquired. Humicrobiota conferred many changes upon the WT model in contrast to previous results, which showed only colonization with no disease after C. jejuni challenge. When compared to Convmicrobiota mice for susceptibility to C. jejuni enteric or GBS patient strains, infected Humicrobiota mice had (1) 10-100 fold increases in C. jejuni colonization of both strains, (2) pathologic change in draining lymph nodes but only mild changes in colon or cecal lamina propria, (3) significantly lower Th1/Th17-dependent anti- C. jejuni responses, (4) significantly higher IL-4 responses at 5 but not 7?weeks post infection (PI), (5) significantly higher Th2-dependent anti- C. jejuni responses, and (6) significantly elevated anti-ganglioside autoantibodies after C. jejuni infection. These responses in Humicrobiota mice were correlated with a dominant Bacteroidetes and Firmicutes microbiota. ConclusionsThese data demonstrate that Humicrobiota altered host-pathogen interactions in infected mice, increasing colonization and Th-2 and autoimmune responses in a C. jejuni strain-dependent manner. Thus, microbiota composition is another factor controlling susceptibility to GBS.
机译:背景空肠弯曲杆菌是自身免疫性神经病性格林-巴利综合征(GBS)的主要先行感染,伴有对周围神经的自身免疫性抗神经节苷脂抗体攻击。以前,我们显示了不同的免疫反应介导空肠弯曲杆菌诱导的结肠炎和白细胞介素10(IL-10)缺陷小鼠的自身免疫,具体取决于感染株。来自结肠炎患者的菌株引起T辅助1(T H 1)依赖性炎症反应,而来自GBS患者的菌株引起T H 2依赖性自身抗体产生。微生物群的抗生素耗竭加剧了这两种综合症,但控制GBS敏感性的其他因素尚不清楚。方法使用16S rRNA基因高通量测序技术,检查肠道微生物群落的结构是否改变了宿主(1)胃肠道炎症或(2)空肠弯曲杆菌菌株感染大肠炎或GBS患者后的抗神经节苷脂抗体反应。我们比较了C57BL / 6小鼠与(1)稳定的人类肠道菌群( Hu 微生物群)移植物或(2)常规小鼠菌群( Conv 微生物群)的反应。结果用混合的人粪便接种无菌C57BL / 6野生型(WT)小鼠提供了一种鼠模型,该模型稳定地通过了超过20代的微生物群。将小鼠关在特定的无病原体(SPF)设施中,同时采取额外的预防措施,让看护人穿上无菌的衣服,并限制出入,确保没有老鼠的病原体。与先前的结果相反, Hu 微生物群对野生型模型赋予了许多变化,先前的结果表明空肠弯曲杆菌攻击后仅定植而没有疾病。与 Conv 菌群小鼠相比,空肠弯曲杆菌肠杆菌或GBS患者菌株易感性高,被感染的 Hu 菌群小鼠具有(1)空肠弯曲菌定植增加10-100倍(2)引流淋巴结的病理变化,但结肠或盲肠固有层仅有轻度变化,(3)Th1 / Th17依赖性抗空肠弯曲杆菌反应明显降低,(4)IL-4反应明显升高在感染后5周而不是7周时(PI),(5)空肠弯曲杆菌感染后,依赖Th2的抗空肠弯曲杆菌反应明显升高,(6)抗神经节苷脂自身抗体显着升高。 Husups微生物群小鼠中的这些反应与显性的拟杆菌属和Firmicutes微生物群相关。结论这些数据表明, Hu 微生物群以空肠弯曲杆菌菌株依赖性方式改变了感染小鼠的宿主-病原体相互作用,增加了定植,Th-2和自身免疫反应。因此,微生物群组成是控制对GBS敏感性的另一个因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号